Cargando…
Serum and Plasma Metabolomic Biomarkers for Lung Cancer
In drug invention and early disease prediction of lung cancer, metabolomic biomarker detection is very important. Mortality rate can be decreased, if cancer is predicted at the earlier stage. Recent diagnostic techniques for lung cancer are not prognosis diagnostic techniques. However, if we know th...
Autores principales: | Kumar, Nishith, Shahjaman, Md., Mollah, Md. Nurul Haque, Islam, S. M. Shahinul, Hoque, Md. Aminul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512859/ https://www.ncbi.nlm.nih.gov/pubmed/28729763 http://dx.doi.org/10.6026/97320630013202 |
Ejemplares similares
-
Metabolomic Biomarker Identification in Presence of Outliers and Missing Values
por: Kumar, Nishith, et al.
Publicado: (2017) -
Robust Feature Selection Approach for Patient Classification using Gene Expression Data
por: Shahjaman, Md., et al.
Publicado: (2017) -
A Robust Approach for Identification of Cancer Biomarkers and Candidate Drugs
por: Shahjaman, Md., et al.
Publicado: (2019) -
Robust Significance Analysis of Microarrays by Minimum β-Divergence Method
por: Shahjaman, Md., et al.
Publicado: (2017) -
Biomarker Identification from RNA-Seq Data using a Robust Statistical Approach
por: Akond, Zobaer, et al.
Publicado: (2018)